Actively Recruiting
Guided Cardiovascular-Kidney-Metabolic Therapy After Heart Attack Using Rapid ESC Protocol
Led by Zuyderland Medisch Centrum · Updated on 2026-08-19
1215
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating whether rapid, guideline-based treatment after a heart attack can improve patient outcomes. This study focuses on managing key health issues like diabetes, high blood pressure, and high cholesterol following acute coronary syndrome treated with percutaneous coronary intervention. The goal is to reduce the risk of major heart and brain-related events over a two-year period and improve patients quality of life and longevity. Participants in the intervention group will receive care following a rapid protocol based on European Society of Cardiology guidelines. This includes optimized medication for lowering lipids, controlling blood pressure, and managing diabetes with drugs such as SGLT-2 inhibitors and GLP-1 agonists. The study compares this approach to standard care to see if earlier and more intensive treatment reduces complications. During the study, patients will be monitored for major adverse cardiac and cerebrovascular events for two years after their heart attack and intervention. Quality of life surveys and health checklists will be collected at 30 days, one year, and two years after discharge. The study aims to establish an effective and practical prevention strategy to improve health outcomes and reduce healthcare needs over time.
CONDITIONS
Brief Title
Cardiovascular-kidney-metabolic (CKM)-Guided Therapy for Patients After Acute Coronary Syndrome
Research Team
S
Stan Toonen, MSc
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here